Oxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down – What’s Next?

Shares of Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $12.35, but opened at $11.05. Oxford BioMedica shares last traded at $11.11, with a volume of 10,000 shares changing hands.

Oxford BioMedica Trading Down 4.7%

The company has a quick ratio of 1.67, a current ratio of 1.89 and a debt-to-equity ratio of 3.08. The firm has a 50 day moving average price of $9.52 and a two-hundred day moving average price of $8.15.

About Oxford BioMedica

(Get Free Report)

Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.

In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.

Read More

• Five stocks we like better than Oxford BioMedica
• This is the Exact Moment the AI Boom Will End
• New gold price target
• Bombshell Exposé on China Strikes
• End of America Update
• Trump’s Final Shocking Act Begins February 24